Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

By C. Weenen, J. Laven, A. V. von Bergh, M. Cranfield, N. Groome, J. Visser, P. Kramer, Bart C. J. M. Fauser, A. Themmen. Molecular human reproduction, 2004

1,325 citations recorded by the source corpus.

Subfields: Public Health, Environmental and Occupational Health, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/b7816ccb78efe57ff7660447e7d0e36aea99b19f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Public Health, Environmental and Occupational Health

1. Bart C. J. M. Fauser
2. Frank J. Broekmans

In Reproductive Medicine

1. Bart C. J. M. Fauser
2. J. Laven
3. Frank J. Broekmans
4. S. Broer

Citations in the corpus

• Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. (2014, background): “…aging than others; i.e. her individual AMH concentration may be similar to mean levels of women at age 45 years (Kelsey et al., Figure 1 Anti-Müllerian hormone (AMH) immunohistochemical staining in human ovarian tissue sections, along with the graphical summary data, from Weenen et al. (2004).”
• Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). (2010, background): “reached the size and differentiation state at which they are selected for dominance by the action of pituitary FSH (Weenen et al., 2004) (Fig.”